olsalazine has been researched along with Thrombopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rao, Y; Zheng, F | 1 |
| Benoit, R; Bichoffe, A; Dol, L; Grobost, O | 1 |
2 other study(ies) available for olsalazine and Thrombopenia
| Article | Year |
|---|---|
Thrombocytopenia associated with 5-aminosalicylate prodrug, olsalazine: is the devil still there?
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Female; Hospitalization; Humans; Middle Aged; Prodrugs; Severity of Illness Index; Thrombocytopenia | 2013 |
[Thrombopenia during 5-ASA treatment (mesalazine and olsalazine)].
Topics: Adolescent; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Mesalamine; Thrombocytopenia | 1999 |